Table 1.
Clinicopathological characteristics of 86 patients with PTMC
| Clinicopathologic characteristics | Patients (n) | Percentage (%) |
|---|---|---|
| Gender | ||
| Male | 8 | 9.3 |
| Female | 78 | 90.7 |
| Age, yr | 43.7 ± 10.3 | |
| ≥ 45 | 41 | 47.7 |
| < 45 | 45 | 52.3 |
| Tumor size, mm | 6.8 ± 2.2 | |
| 5 < and ≤ 10 | 58 | 67.4 |
| ≤ 5 | 28 | 32.6 |
| Multifocality | ||
| Multiple (≥ 2) | 5 | 5.8 |
| Single | 81 | 94.2 |
| Extrathyroid invasion | ||
| Yes | 3 | 3.5 |
| No | 83 | 96.5 |
| Hashimoto’s disease | ||
| Yes | 17 | 19.8 |
| No | 69 | 80.2 |
| Lymph node metastases | ||
| Yes | 22 | 25.6 |
| No | 64 | 74.4 |
| T stage* | ||
| T3 | 2 | 2.3 |
| T1 | 84 | 97.7 |
| BRAFV600E mutation | ||
| Yes | 56 | 65.1 |
| No | 30 | 34.9 |
*
TNM stage is based on the AJCC Cancer Staging Manual, 7th edition (2010).